Get started
Author

Fulya Erendor

Observed names: ERENDOR, FULYA, Erendor, Fulya, FULYA ERENDOR
ORCID: 0000-0002-0726-803X
Observed ORCID: 0000-0002-0726-803X
OpenAlex ID: A5023162362
Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects
2025 · Busra Cetin, Fulya Erendor, et al. · Expert Reviews in Molecular Medicine · 84
Gene and cell therapy of human genetic diseases: Recent advances and future directions
2024 · Busra Cetin, Fulya Erendor, et al. · Journal of Cellular and Molecular Medicine · 46
PDF
Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes
2020 · Fulya Erendor, Yunus Emre Eksi, et al. · Molecular Therapy · 29
PDF
Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation
2020 · Fulya Erendor, Elif Ozgecan Sahin, et al. · Gene Therapy · 18
Prime Editing: The Next Frontier in Precision Gene Therapy
2025 · Melike Aliciaslan, Ezgi Erbasan, et al. · The Journal of Gene Medicine · 13
SARS‐CoV‐2 Variants and Immune Evasion: Mapping the Future of Vaccine Design
2026 · Fatih Uzer, Fulya Erendor, et al. · Reviews in Medical Virology · 6
Advances in CRISPR Base Editing: From Molecular Evolution to Therapeutic Applications in Genomic Medicine
2026 · Melike Aliciaslan, Ezgi Erbasan, et al. · Journal of Cellular and Molecular Medicine · 6
Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease
2025 · Ezgi Erbasan, Melike Aliciaslan, et al. · Gene Therapy · 6
Microglia cells treated with synthetic vasoactive intestinal peptide or transduced with LentiVIP protect neuronal cells against degeneration
2024 · Azize Yasemin Goksu, Fatma Gonca Kocanci, et al. · European Journal of Neuroscience · 6
PDF
Lantidra (donislecel) in type 1 diabetes: An in‐depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA ‐approved allogeneic islet cell therapy
2025 · Ezgi Erbasan, Melike Aliciaslan, et al. · Diabetic Medicine · 3
An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice
2026 · Fulya Erendor, Fatih Uzer, et al. · Biotechnology Journal · 2
Lentiviral GLP-1 gene therapy elicits developmental stage–dependent β-cell regeneration in diabetic rats
2026 · Ezgi Erbasan, Melike Aliciaslan, et al. · Journal of Molecular Medicine · 1
PDF
Author response for "Microglia cells treated with synthetic vasoactive intestinal peptide or transduced with LentiVIP protect neuronal cells against degeneration"
2024 · Goksu, Azize Yasemin, Kocanci, Fatma Gonca, et al. · Publons reviews and discussion
Author response for "Microglia cells treated with synthetic vasoactive intestinal peptide or transduced with LentiVIP protect neuronal cells against degeneration"
2023 · Goksu, Azize Yasemin, Kocanci, Fatma Gonca, et al. · Publons reviews and discussion
Construction of a lentiviral vector-carrying SARS-CoV-2 spike gene for COVID-19
2021 · ORAL, HALUK BARBAROS, ŞANLIOĞLU, SALİH, et al. · Bursa Uludag University - AVESIS
İnsülin Gen Naklinin Geçmiş ve Geleceği
2021 · Fulya Erendor, Yunus Emre Ekşi, et al. · Turkiye Klinikleri Tip Bilimleri Dergisi
Combined Efficacy of Insulin and Anti-Inflammatory Gene Therapies for Type 1 Diabetes Mellitus
2021 · Fulya Erendor, Yunus Emre Ekşi, et al. · Molecular Therapy
Generation of a Novel Gene Therapy Vector Encoding Beta-Cell–Specific Insulin for Diabetes Treatment
2018 · ELIF O. SAHIN, FULYA ERENDOR, et al. · Diabetes
Works count: 19
Citation count: 220
H-index: 6
I10-index: 5
Year
Topic
Type